GERM vs. BCHP ETF Comparison

Comparison of ETFMG Treatments Testing and Advancements ETF (GERM) to Principal Focused Blue Chip ETF (BCHP)

GERM

ETFMG Treatments Testing and Advancements ETF

GERM Description

GERM is designed to give direct exposure to the biotech companies directly engaged in the testing and treatments of infectious diseases. Focused on advancements with targeted exposure to the forefront of R&D, vaccines, therapies and testing technologies.

Grade (RS Rating)

Last Trade

$19.16

Average Daily Volume

1,248

Number of Holdings ^*

* may have additional holdings in another (foreign) market

BCHP

Principal Focused Blue Chip ETF

BCHP Description

Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies with large market capitalizations at the time of purchase that, in the opinion of Principal Global Investors, LLC ("PGI"), the fund"s investment advisor, display characteristics of a "blue chip" company. Blue chip companies are firms that, in PGI"s view, are well established in their industries and have the potential for growth of capital and an expectation for above-average earnings. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$32.80

Average Daily Volume

22,102

Number of Holdings ^*

* may have additional holdings in another (foreign) market

Performance

Period	GERM	BCHP
30 Days	3.00%	1.18%
60 Days	3.68%	5.24%
90 Days	-2.06%	0.74%
12 Months	-0.17%	35.99%

0 Overlapping Holdings

	Symbol	Grade	Weight in GERM	Weight in BCHP	Overlap

GERM Overweight 2 Positions Relative to BCHP

	Symbol	Grade	Weight
	SCLX	F	0.0%
	INO	F	0.0%

GERM Underweight 9 Positions Relative to BCHP

Symbol	Grade	Weight
MSFT	D	-13.2%
GOOG	B	-11.56%
AMZN	C	-11.36%
MA	A	-6.94%
TDG	A	-5.05%
PGR	C	-4.85%
DHR	C	-4.4%
V	C	-4.34%
INTU	F	-3.64%

GERM: Top Represented Industries & Keywords

Industries: Biotechnology Drug Manufacturers - General